Publications by authors named "Louis Clearkin"

Claim this Profile
C
Correction: Is no test better than a bad test: Impact of diagnostic uncertainty on the spread of COVID-19.
Nicholas Gray, Dominic Calleja, Alexander Wimbush, Enrique Miralles-Dolz, Ander Gray, Louis Clearkin

PLoS One· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.
Bright Uchenna Oparaji, Louis Clearkin, Scott Ferson, Marco De Angelis, Maria Ferrer-Fernandez

Rheumatology (Oxford)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19.
Nicholas Gray, Dominic Calleja, Alexander Wimbush, Enrique Miralles-Dolz, Ander Gray, Louis Clearkin

PLoS One· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies.
Louis Clearkin, Balasubramanian Ramasamy, James Wason, Stephenie Tiew

BMJ Open Ophthalmol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concerns over Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
Louis Clearkin

Eur J Ophthalmol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes to the law on consent following Montgomery vs Lanarkshire Health Board.
Louis Clearkin

Br J Hosp Med (Lond)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and autoregulatory dysfunction in glaucoma and retinal vein occlusion.
Rosalind M K Stewart, Louis G Clearkin

Am J Ophthalmol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
Rosalind M K Stewart, Louis G Clearkin

Am J Ophthalmol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gabapentin may cause reversible visual field constriction: GABA transaminase inhibitors may cause irreversible visual field loss.
Jon M Durnian, Louis G Clearkin

BMJ· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Birdshot chorioretinopathy.
Shabbir Harun, Louis G Clearkin

Ophthalmology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis